LivaNova (LIVN)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$81.92+0.89%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · LIVN
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||
| Revenues | 1,471.5 | 1,388.1 | 1,253.4 | 1,153.5 | 1,021.8 | 1,035.4 | 934.2 | 1,084.2 | 1,107.0 | 1,012.3 | 964.9 | 291.6 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 1,012.3 | 964.9 | 291.6 |
| Cost of Revenues | 469.5 | 448.2 | 382.6 | 397.7 | 314.6 | 329.4 | 339.5 | — | 361.3 | 353.2 | 367.8 | 27.3 |
| Gross Profit | 1,002.0 | 939.9 | 870.9 | 755.8 | 707.2 | 706.0 | 594.8 | — | — | 651.6 | 559.5 | 264.2 |
| Operating Expenses & Income | ||||||||||||
| Selling, General & Admin | 583.6 | 548.8 | 526.3 | 502.7 | 469.2 | 471.9 | 446.6 | 528.5 | 465.0 | 380.1 | 355.2 | 123.6 |
| R&D Expenses | 213.1 | 185.8 | 182.5 | 193.8 | 155.8 | 183.4 | 152.9 | 146.8 | 145.9 | 109.5 | 82.1 | 42.2 |
| Other Operating Expenses, Total | (17.9) | (5.9) | (33.0) | (37.8) | (29.5) | (51.5) | — | — | — | — | — | — |
| Operating Income | 187.5 | 199.4 | 129.1 | (68.5) | (76.8) | (0.8) | (273.9) | (171.6) | (248.1) | 96.5 | 33.4 | 88.7 |
| Earnings from Continuing Operations | ||||||||||||
| Interest Expense | — | 49.3 | 63.1 | 58.9 | 48.3 | 50.2 | 40.8 | 15.1 | 9.8 | 7.8 | 10.6 | 0.0 |
| Interest & Investment Income | 15.7 | 19.0 | — | 22.0 | 4.7 | 0.4 | 0.1 | 0.8 | 0.8 | 1.3 | 1.7 | 0.2 |
| Net Interest Expenses | — | — | — | 36.8 | 43.6 | 49.7 | 40.7 | 14.3 | 9.0 | 6.5 | 8.9 | (0.2) |
| Other Non-Operating Income / Expenses | (39.4) | (2.7) | — | 46.1 | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | 107.5 | (220.8) | 88.3 | (81.2) | (75.1) | (124.5) | (348.0) | (188.4) | (247.4) | 121.1 | 25.7 | 89.3 |
| Income Tax Expense | (82.0) | 21.6 | 25.1 | (98.9) | 11.1 | 11.2 | (1.0) | (30.4) | (69.6) | 50.0 | 5.1 | 31.4 |
| Net Income | ||||||||||||
| Net Income | 188.5 | (242.5) | 63.2 | 17.6 | (86.2) | (135.8) | (348.8) | (157.6) | (189.4) | (25.1) | (62.8) | 57.8 |
| Per Share | ||||||||||||
| Basic EPS | 3.43 | (4.45) | 1.17 | 0.33 | (1.61) | (2.68) | (7.18) | (3.21) | (3.91) | (0.52) | (1.29) | 2.19 |
| Diluted EPS | 3.35 | (4.45) | 1.16 | 0.32 | (1.61) | (2.68) | (7.18) | (3.26) | (3.91) | (0.52) | (1.28) | 2.17 |
| Revenue per Share | 26.15 | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 55.0 | 54.5 | 54.2 | 53.9 | 53.5 | 50.6 | 48.6 | 48.3 | 48.5 | 48.2 | 48.9 | 26.4 |
| Diluted Weighted Avg Shares | 56.3 | 54.5 | 54.6 | 54.2 | 53.5 | 50.6 | 48.6 | 48.3 | 48.5 | 48.5 | 49.0 | 26.6 |
| Supplemental | ||||||||||||
| EBITDA | — | — | — | — | — | — | — | — | — | — | 118.8 | 95.5 |
| EBIT | 187.5 | 199.4 | 129.1 | (68.5) | (76.8) | (0.8) | (273.9) | (171.6) | (248.1) | 96.5 | 33.4 | 88.7 |
| Effective Tax Rate | -76.3% | — | — | 121.7% | -14.7% | -9.0% | 0.3% | 16.1% | 28.1% | 41.2% | 19.9% | 35.2% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.